Access to Limited Distribution Drug Through Development of Generics: A Treprostinil Case Study for Treatment of Pulmonary Arterial Hypertension
Tuesday, April 7, 2020
12:30 PM – 1:00 PM
In this session the attendee will receive a disease state overview of PAH, the history of the limited distribution drug model that has been utilized to treat this disease and how generic development is now allowing more pharmacies to be able to care for PAH patients. A case study of treprostinil will be used for illustrative purposes.